Literature DB >> 16454558

Interference of blood cell lysis on routine coagulation testing.

Giuseppe Lippi1, Martina Montagnana, Gian Luca Salvagno, Gian Cesare Guidi.   

Abstract

CONTEXT: Preanalytical factors influencing the reliability of laboratory testing are commonplace. It is traditionally accepted that hemolytic samples are unsuitable for coagulation assays because of the release of hemoglobin, intracellular components, and thromboplastic substances from damaged blood cells.
OBJECTIVE: To evaluate the influence of blood cell lysis on routine coagulation testing.
DESIGN: Twelve aliquots prepared by serial dilutions of homologous lysated samples collected from 10 different subjects, and displaying a final percentage of lysis ranging from 0% to 9.1%, were tested for prothrombin time, activated partial thromboplastin time, fibrinogen, and dimerized plasmin fragment D. Lysis was achieved by subjecting citrated whole blood to a freeze-thaw cycle. OUTCOME MEASURES: Interference from blood cell lysis on routine coagulation testing.
RESULTS: Statistically significant increases in prothrombin time and dimerized plasmin fragment D were observed in samples containing final lysate concentrations of 0.5% and 2.7% respectively, whereas significant decreases were observed in activated partial thromboplastin time and fibrinogen in samples containing a final lysate concentration of 0.9%. The current analytical quality specifications for desirable bias are +/-2.0% for prothrombin time, +/-2.3% for activated partial thromboplastin time, and +/-4.8% for fibrinogen. Percent variations from the baseline values exceeding the current analytical quality specifications for desirable bias were achieved for lysate concentrations of 0.9% (prothrombin time and activated partial thromboplastin time) and 1.8% (fibrinogen), corresponding to average free plasma hemoglobin concentrations of 1.7 and 3.4 g/L, respectively.
CONCLUSION: Our results confirm that, although slightly hemolyzed specimens might still be analyzable, a moderate blood cell lysis, as low as 0.9%, influences the reliability of routine coagulation testing. Because the interference in coagulation assays has a wide interindividual bias, we do not recommend lysis correction and we suggest that the most appropriate corrective measure should be free hemoglobin quantification and sample recollection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454558     DOI: 10.5858/2006-130-181-IOBCLO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Optical and mechanical clot detection methodologies: a comparison study for routine coagulation testing.

Authors:  Nilgun Tekkesin; Cumhur Kılınc
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

Review 2.  Pre-analytic variability in cardiovascular biomarker testing.

Authors:  Roberto Cemin; Massimo Daves
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  Discrepancy in optical & mechanical method in coagulation tests in a turbid sample.

Authors:  Swati Aggarwal; Deepak M Nayak; Chethan Manohar
Journal:  Indian J Hematol Blood Transfus       Date:  2014-08-17       Impact factor: 0.900

4.  A retrospective analysis of the incidence of hemolysis in type and screen specimens from trauma patients.

Authors:  Kavin G Shah; Juan P Idrovo; Jeffrey Nicastro; Heather F McMullen; Ernesto P Molmenti; Gene Coppa
Journal:  Int J Angiol       Date:  2009

5.  Quantitative assessment of prevalence of pre-analytical variables and their effect on coagulation assay. Can intervention improve patient safety?

Authors:  Ravi Bhushan; Arijit Sen
Journal:  Med J Armed Forces India       Date:  2017-01-05

6.  Cell lysis via acoustically oscillating sharp edges.

Authors:  Zeyu Wang; Po-Hsun Huang; Chuyi Chen; Hunter Bachman; Shuaiguo Zhao; Shujie Yang; Tony J Huang
Journal:  Lab Chip       Date:  2019-11-13       Impact factor: 6.799

7.  A dyspnea patient with abnormal prolonged prothrombin time and activated partial thromboplstin time, but without bleeding symptoms.

Authors:  Zhi-de Hu; Bing Gu; An-Mei Deng
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

8.  Hemolyzed Samples Should be Processed for Coagulation Studies: The Study of Hemolysis Effects on Coagulation Parameters.

Authors:  S Arora; S Kolte; Js Dhupia
Journal:  Ann Med Health Sci Res       Date:  2014-03

9.  A collaborative study by the Working Group on Hemostasis and Thrombosis of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) on the interference of haemolysis on five routine blood coagulation tests by evaluation of 269 paired haemolysed/non-haemolysed samples.

Authors:  Chiara Novelli; Matteo Vidali; Bruno Brando; Benedetto Morelli; Giovanna Andreani; Marina Arini; Paola Calzoni; Roberta Giacomello; Barbara Montaruli; Emanuela Muccini; Angela Papa; Paola Pradella; Lucia Ruocco; Fosca Siviero; Filomena Gemma Viola; Mario Zanchetta; Lorena Zardo; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

10.  European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE).

Authors:  Janne Cadamuro; Giuseppe Lippi; Alexander von Meyer; Mercedes Ibarz; Edmee van Dongen; Michael Cornes; Mads Nybo; Pieter Vermeersch; Kjell Grankvist; Joao Tiago Guimaraes; Gunn B B Kristensen; Barbara de la Salle; Ana-Maria Simundic
Journal:  Biochem Med (Zagreb)       Date:  2019-06-15       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.